Recently, both our group and another group found that METCAM was upregulated in human ovarian cancer specimens, suggesting that METCAM may be a marker for the poor prognosis of ovarian cancer patients [14, 32], and that METCAM may play a positive role in the development of ovarian cancer [14, 32]. The gene discussed is MCAM; the disease is ovarian carcinoma.